Drug Delivery Devices – Market Insights – Europe (Supplemental)
The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-cost generic drug delivery devices will support rising overall sales volumes, which will be further supported by expanding patient populations.
This Medtech 360 Report provides high-level market metrics for Drug Delivery Devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
